Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2012

01.04.2012 | Breast Oncology

Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period

verfasst von: Lucio Fortunato, MD, Alessandra Mascaro, MD, Igor Poccia, MD, Renato Andrich, MD, Mostafà Amini, MD, Leopoldo Costarelli, MD, Giuliana Cortese, MD, Massimo Farina, MD, Carlo Vitelli, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Invasive lobular carcinoma (ILC) is believed to be more often multicentric and bilateral compared with invasive ductal cancer (IDC), leading clinicians to pursue a more aggressive local and contralateral approach.

Methods

Retrospective review of a consecutive cohort of breast cancer patients operated at one institution from January 2000 to January 2010 was performed. Median follow-up was 4 years.

Results

There were 171 ILC (14.5%) and 1,011 IDC patients in the study period. Median age (63 vs. 65 years) and tumor diameter (1.7 cm) were similar in the two groups. Diagnoses of ILC were more frequent in the second half of the study period (55/465 vs. 116/662, p < 0.01). Multicentricity was reported in 108/1,011 (10.6%) IDC and in 31/171 (18.1%) ILC patients (p < 0.01). A positive margin of resection at initial surgery was documented in 71/1,011 (7%) IDC and in 21/171 (12.3%) ILC patients (p < 0.001). Although the rate of mastectomy decreased over time in both groups, this was more pronounced for ILC patients (p < 0.001). Locoregional control, contralateral cancer, overall survival, disease-free survival, and survival according to diameter, nodal status, and type of surgical intervention did not differ between IDC and ILC. On multivariate analysis, stage of disease and hormone receptor status were associated with disease-free survival, but histology was not.

Conclusions

Although ILC is more often multicentric, bilateral, and associated with a positive margin of resection, local control and survival are similar to IDC. ILC can be treated similarly to IDC with good results.
Literatur
1.
Zurück zum Zitat Foote FW Jr, Stewart FW. A histologic classification of carcinoma of the breast. Surgery. 1946;19:74–99.PubMed Foote FW Jr, Stewart FW. A histologic classification of carcinoma of the breast. Surgery. 1946;19:74–99.PubMed
2.
Zurück zum Zitat Bouvet M, Ollila DW, Hunt KK et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:650–54.PubMedCrossRef Bouvet M, Ollila DW, Hunt KK et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:650–54.PubMedCrossRef
3.
Zurück zum Zitat Orvieto E, Maiorano E, Bottiglieri L et al. Clinicopathologic characteristics of invasive lobular carcinoma of the breast. Cancer. 2008;113:1511–20.PubMedCrossRef Orvieto E, Maiorano E, Bottiglieri L et al. Clinicopathologic characteristics of invasive lobular carcinoma of the breast. Cancer. 2008;113:1511–20.PubMedCrossRef
4.
Zurück zum Zitat Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545–50.PubMedCrossRef Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545–50.PubMedCrossRef
5.
Zurück zum Zitat Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ. Infiltrating lobular carcinoma—a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. The Breast. 2004;13:389–96.PubMedCrossRef Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ. Infiltrating lobular carcinoma—a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. The Breast. 2004;13:389–96.PubMedCrossRef
6.
Zurück zum Zitat Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113–20.PubMedCrossRef Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113–20.PubMedCrossRef
7.
Zurück zum Zitat Mallon E, Varga Z: relapse of invasive lobular carcinoma. Breast Dis. 2009;30:53–6.PubMed Mallon E, Varga Z: relapse of invasive lobular carcinoma. Breast Dis. 2009;30:53–6.PubMed
8.
Zurück zum Zitat Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6:R149–56.PubMedCrossRef Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6:R149–56.PubMedCrossRef
9.
Zurück zum Zitat McGuire KP, Santillan AA, Kaur P. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682–90.PubMedCrossRef McGuire KP, Santillan AA, Kaur P. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682–90.PubMedCrossRef
10.
Zurück zum Zitat Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef
11.
Zurück zum Zitat Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2003;98:697–702.PubMedCrossRef Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2003;98:697–702.PubMedCrossRef
12.
Zurück zum Zitat Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of breast: presentation, treatment, and outcomes. JACS. 1998;186:416–22. Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of breast: presentation, treatment, and outcomes. JACS. 1998;186:416–22.
13.
Zurück zum Zitat Salvadori B, Biganzoli E, Veronesi P, et al. Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg. 1997;84:106–9.PubMedCrossRef Salvadori B, Biganzoli E, Veronesi P, et al. Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg. 1997;84:106–9.PubMedCrossRef
14.
Zurück zum Zitat Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE. Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol. 1997;4:198–202.PubMedCrossRef Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE. Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol. 1997;4:198–202.PubMedCrossRef
15.
Zurück zum Zitat Peiro G, Bornstein BA, Connolly JL. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2000;59:49–54.PubMedCrossRef Peiro G, Bornstein BA, Connolly JL. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2000;59:49–54.PubMedCrossRef
16.
Zurück zum Zitat Mersin H, Yildrim E, Gulben K, Berberoglu U: Is invasive lobular carcinoma different from invasive ductal carcinoma? EJSO. 2003;29:390–5.PubMed Mersin H, Yildrim E, Gulben K, Berberoglu U: Is invasive lobular carcinoma different from invasive ductal carcinoma? EJSO. 2003;29:390–5.PubMed
17.
Zurück zum Zitat Santiago RJ, Harris EER, Qin L. Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast. Cancer. 2005;103:2447–54.PubMedCrossRef Santiago RJ, Harris EER, Qin L. Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast. Cancer. 2005;103:2447–54.PubMedCrossRef
18.
Zurück zum Zitat Vo TN, Meric-Bernstam F, Yi M, et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg. 2006;192:552–5.PubMedCrossRef Vo TN, Meric-Bernstam F, Yi M, et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg. 2006;192:552–5.PubMedCrossRef
19.
Zurück zum Zitat Fritz P, Klenk S, Goletz S, et al. Clinical impacts of histological subtyping primary breast cancer. Anticancer Res. 2010;30:5137–44.PubMed Fritz P, Klenk S, Goletz S, et al. Clinical impacts of histological subtyping primary breast cancer. Anticancer Res. 2010;30:5137–44.PubMed
20.
Zurück zum Zitat Fortunato L, Mascaro A, Amini M, Farina M, Vitelli CE. Sentinel lymph node biopsy in breast cancer. Surg Oncol Clin North Am. 2008;17:673–99.CrossRef Fortunato L, Mascaro A, Amini M, Farina M, Vitelli CE. Sentinel lymph node biopsy in breast cancer. Surg Oncol Clin North Am. 2008;17:673–99.CrossRef
21.
Zurück zum Zitat Mann RM. The effectiveness of MR Imaging in the assessment of invasive lobular carcinoma of the breast. Magn Reson Imaging Clin North Am. 2010;18:259–76.CrossRef Mann RM. The effectiveness of MR Imaging in the assessment of invasive lobular carcinoma of the breast. Magn Reson Imaging Clin North Am. 2010;18:259–76.CrossRef
22.
Zurück zum Zitat Furman B, Gardner MS, Romilly P, et al. Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. Am J Surg. 2003;186:344–7.PubMedCrossRef Furman B, Gardner MS, Romilly P, et al. Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. Am J Surg. 2003;186:344–7.PubMedCrossRef
23.
Zurück zum Zitat Brem RF, Ioffe M, Rapelyea JA, Yost KG, Weigert JM, Bertrand ML, Stern LH. Invasive lobular carcinoma; detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR. 2009;192:379–83.PubMedCrossRef Brem RF, Ioffe M, Rapelyea JA, Yost KG, Weigert JM, Bertrand ML, Stern LH. Invasive lobular carcinoma; detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR. 2009;192:379–83.PubMedCrossRef
24.
Zurück zum Zitat Siegmann KC, Baur A, Vogel U, Kraemer B, Hahn M, Claussen CD. Risk–benefit analysis of preoperative breast MRI in patients with primary breast cancer. Clin Radiol. 2009;64:403–13.PubMedCrossRef Siegmann KC, Baur A, Vogel U, Kraemer B, Hahn M, Claussen CD. Risk–benefit analysis of preoperative breast MRI in patients with primary breast cancer. Clin Radiol. 2009;64:403–13.PubMedCrossRef
25.
Zurück zum Zitat Wagner PL, Kitabayashi N, Chen YT, Shin SJ. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast. A molecular study of 10 cases. Am J Clin Pathol. 2009;132:871–6.PubMedCrossRef Wagner PL, Kitabayashi N, Chen YT, Shin SJ. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast. A molecular study of 10 cases. Am J Clin Pathol. 2009;132:871–6.PubMedCrossRef
26.
Zurück zum Zitat De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenina in invasive lobular breast canceer and lobular carcinoma in situ. J Pathol. 1997; 183:404–11.PubMedCrossRef De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenina in invasive lobular breast canceer and lobular carcinoma in situ. J Pathol. 1997; 183:404–11.PubMedCrossRef
27.
Zurück zum Zitat Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res. 2002;4:5–8.PubMedCrossRef Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res. 2002;4:5–8.PubMedCrossRef
28.
Zurück zum Zitat Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36:1–85.PubMedCrossRef Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36:1–85.PubMedCrossRef
29.
Zurück zum Zitat Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 2000;88:2561–69.PubMedCrossRef Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 2000;88:2561–69.PubMedCrossRef
30.
Zurück zum Zitat Choi YJ, Pinto MM, Hao L, Riba AK. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol. 2008;21:1224–37. Epub 2008 Jun 27.PubMedCrossRef Choi YJ, Pinto MM, Hao L, Riba AK. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol. 2008;21:1224–37. Epub 2008 Jun 27.PubMedCrossRef
31.
Zurück zum Zitat Longacre TA, Ennis M, Quennevill LA, et al. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol. 2006;19:195–207.PubMedCrossRef Longacre TA, Ennis M, Quennevill LA, et al. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol. 2006;19:195–207.PubMedCrossRef
32.
Zurück zum Zitat Wasif N, Maggard MA, Ko CY, Giuliano AE. Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol. 2010;17:1862–9.PubMedCrossRef Wasif N, Maggard MA, Ko CY, Giuliano AE. Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol. 2010;17:1862–9.PubMedCrossRef
33.
Zurück zum Zitat Silverstein MJ, Lewinsky BS, Waisman JR, Gierson Ed, Colburn WJ, Senofsky GM, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73:1673–7.PubMedCrossRef Silverstein MJ, Lewinsky BS, Waisman JR, Gierson Ed, Colburn WJ, Senofsky GM, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73:1673–7.PubMedCrossRef
34.
Zurück zum Zitat Ashikari R, Huvos AG, Urban JA, Robbins GF. Infiltrating lobular carcinoma of the breast. Cancer. 1973;31:110–6.PubMedCrossRef Ashikari R, Huvos AG, Urban JA, Robbins GF. Infiltrating lobular carcinoma of the breast. Cancer. 1973;31:110–6.PubMedCrossRef
35.
Zurück zum Zitat Lesser M, Rosen PP, Kinne D. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982;91:234–40.PubMed Lesser M, Rosen PP, Kinne D. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982;91:234–40.PubMed
36.
Zurück zum Zitat Horn PL, Thompson WD. Risk of contralateral breast cancer: association with histologic, clinical, and therapeutic factors. Cancer. 1988;62:412–24.PubMedCrossRef Horn PL, Thompson WD. Risk of contralateral breast cancer: association with histologic, clinical, and therapeutic factors. Cancer. 1988;62:412–24.PubMedCrossRef
37.
Zurück zum Zitat Du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blamey RW. Invasive lobular carcinomas of the breast—the prognosis of histopathological subtypes. Br J Cancer. 1989;60:605–9.PubMedCrossRef Du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blamey RW. Invasive lobular carcinomas of the breast—the prognosis of histopathological subtypes. Br J Cancer. 1989;60:605–9.PubMedCrossRef
38.
Zurück zum Zitat Mate TP, Carter D, Fischer DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer. 1986;58:1995–2002.PubMedCrossRef Mate TP, Carter D, Fischer DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer. 1986;58:1995–2002.PubMedCrossRef
39.
Zurück zum Zitat Hussien M, Lioe TF, Finnegan J, Spence RA. Surgical treatment for invasive lobular carcinoma of the breast. Breast. 2003;12:23–35.PubMedCrossRef Hussien M, Lioe TF, Finnegan J, Spence RA. Surgical treatment for invasive lobular carcinoma of the breast. Breast. 2003;12:23–35.PubMedCrossRef
40.
Zurück zum Zitat Viale G, Rotmensz N, Maisonneuve P, et al. Lack of prognostic significance of ‘‘classic’’ lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat. 2009;117:211–4.PubMedCrossRef Viale G, Rotmensz N, Maisonneuve P, et al. Lack of prognostic significance of ‘‘classic’’ lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat. 2009;117:211–4.PubMedCrossRef
41.
Zurück zum Zitat Singletary SE, Patel-Parekh L, Bland KI: Treatment trends in errly-stage invasive lobular carcinoma; A report from the National Cancer Data Base. Ann Surg. 2005;242:281–9.PubMedCrossRef Singletary SE, Patel-Parekh L, Bland KI: Treatment trends in errly-stage invasive lobular carcinoma; A report from the National Cancer Data Base. Ann Surg. 2005;242:281–9.PubMedCrossRef
42.
Zurück zum Zitat Gentilini O, Botteri E, Rotmensz N, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat. 2009;113:577–83. Epub 2008 Mar 11.PubMedCrossRef Gentilini O, Botteri E, Rotmensz N, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat. 2009;113:577–83. Epub 2008 Mar 11.PubMedCrossRef
43.
Zurück zum Zitat Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6. Epub 2009 Jun 9.PubMedCrossRef Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6. Epub 2009 Jun 9.PubMedCrossRef
44.
Zurück zum Zitat Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704.PubMedCrossRef Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704.PubMedCrossRef
45.
Zurück zum Zitat Schnitt SJ, Connolly JL, Recht A, Silver B, Harrir JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer. 1989;64:448–54.PubMedCrossRef Schnitt SJ, Connolly JL, Recht A, Silver B, Harrir JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer. 1989;64:448–54.PubMedCrossRef
46.
Zurück zum Zitat White JR, Gustafson GS, Wimbish K, et al. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. Cancer. 1994;74:640–7.PubMedCrossRef White JR, Gustafson GS, Wimbish K, et al. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. Cancer. 1994;74:640–7.PubMedCrossRef
47.
Zurück zum Zitat Weiss MC, Fowble BL, Solin LJ, Yeh IT, Schultz DL. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 1992;23:941–7.PubMedCrossRef Weiss MC, Fowble BL, Solin LJ, Yeh IT, Schultz DL. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 1992;23:941–7.PubMedCrossRef
48.
Zurück zum Zitat Poen JC, Tran L, Juillard G, et al. Conservation therapy for invasive lobular carcinoma of the breast. Cancer. 1992;69:2789–95.PubMedCrossRef Poen JC, Tran L, Juillard G, et al. Conservation therapy for invasive lobular carcinoma of the breast. Cancer. 1992;69:2789–95.PubMedCrossRef
49.
Zurück zum Zitat Santiago RJ, Wu L, Harris E, Fox J, Schultz D, Glick J, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 2004;58:233–40.PubMedCrossRef Santiago RJ, Wu L, Harris E, Fox J, Schultz D, Glick J, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 2004;58:233–40.PubMedCrossRef
50.
Zurück zum Zitat Haffty BG, Goldberg NB, Rose M, et al. Conservative surgery with radiation therapy in clinical Stage I and II breast cancer. Results of a 20-year experience. Arch Surg. 1989;124:1266–1270.PubMedCrossRef Haffty BG, Goldberg NB, Rose M, et al. Conservative surgery with radiation therapy in clinical Stage I and II breast cancer. Results of a 20-year experience. Arch Surg. 1989;124:1266–1270.PubMedCrossRef
51.
Zurück zum Zitat Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245–51.PubMedCrossRef Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245–51.PubMedCrossRef
52.
Zurück zum Zitat Mansfield CM, Komarnicky LT, Schwartz GF, et al. Ten-year results in 1070 patients with Stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer. 1995;75:2328–36.PubMedCrossRef Mansfield CM, Komarnicky LT, Schwartz GF, et al. Ten-year results in 1070 patients with Stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer. 1995;75:2328–36.PubMedCrossRef
53.
Zurück zum Zitat Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-year results after sector resection with or without postoperative radiotherapy for Stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326–33.PubMed Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-year results after sector resection with or without postoperative radiotherapy for Stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326–33.PubMed
54.
Zurück zum Zitat Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med. 2003;163:2149–53.PubMedCrossRef Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med. 2003;163:2149–53.PubMedCrossRef
55.
Zurück zum Zitat Allemani C, Sant M, Berrino F, et al. Prognostic value of morphology and hormone receptor status in breast cancer—a population-based study. Br J Cancer. 2004;91:1263–8.PubMedCrossRef Allemani C, Sant M, Berrino F, et al. Prognostic value of morphology and hormone receptor status in breast cancer—a population-based study. Br J Cancer. 2004;91:1263–8.PubMedCrossRef
56.
Zurück zum Zitat du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JG, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991;17:251–7.PubMed du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JG, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991;17:251–7.PubMed
57.
Zurück zum Zitat Mhuircheartaigh JN, Curran C, Hennessy E, Kerin MJ. Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma. Br J Surg. 2008;95:827–33.PubMedCrossRef Mhuircheartaigh JN, Curran C, Hennessy E, Kerin MJ. Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma. Br J Surg. 2008;95:827–33.PubMedCrossRef
58.
Zurück zum Zitat Jayasinghe UW, Bilous AM, Boyages J. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J. 2007;13:479–85.PubMedCrossRef Jayasinghe UW, Bilous AM, Boyages J. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J. 2007;13:479–85.PubMedCrossRef
Metadaten
Titel
Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period
verfasst von
Lucio Fortunato, MD
Alessandra Mascaro, MD
Igor Poccia, MD
Renato Andrich, MD
Mostafà Amini, MD
Leopoldo Costarelli, MD
Giuliana Cortese, MD
Massimo Farina, MD
Carlo Vitelli, MD
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2012
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1907-9

Weitere Artikel der Ausgabe 4/2012

Annals of Surgical Oncology 4/2012 Zur Ausgabe

Gastrointestinal Oncology

Parietal Peritonectomy

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.